A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 68.90
-1.20 (-1.71%)
Jul 30, 2026, 12:38 PM CST
A Plus Biotechnology Market Cap
A Plus Biotechnology has a market cap or net worth of 2.39 billion as of July 29, 2026. Its market cap has decreased by -30.91% in one year.
Market Cap
2.39B
Enterprise Value
1.95B
Revenue
858.89M
Ranking
n/a
PE Ratio
13.69
Stock Price
68.90
ChartMarket Cap Chart
Since January 6, 2023, A Plus Biotechnology's market cap has increased from 1.52B to 2.39B, an increase of 56.76%. That is a compound annual growth rate of 13.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 2.39B | -19.20% |
| Dec 31, 2025 | 2.96B | 20.95% |
| Dec 31, 2024 | 2.44B | 77.04% |
| Dec 29, 2023 | 1.38B | -9.40% |
| Jan 6, 2023 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WeLeader Biomedical | 3.20B |
| Applied BioCode | 3.08B |
| Bonraybio | 2.85B |
| Wellell | 2.51B |
| Medimaging Integrated Solution | 2.34B |
| OK Biotech | 2.17B |
| Dynamic Medical Technologies | 2.04B |
| Taiwan Biomaterial | 1.59B |